Scientists track COVID-19's hidden impact on cancer patients
NCT ID NCT04427280
Summary
This study observed 153 cancer patients with suspected COVID-19 to understand how the infection affects them. Researchers tracked their immune responses over time using blood tests to measure COVID-19 antibodies. The goal was to gather information that helps doctors make better decisions about when cancer patients who've had COVID-19 can safely resume their cancer treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Royal Marden NHS Foundation Trust
Sutton, Surrey, SM2 5PT, United Kingdom
Conditions
Explore the condition pages connected to this study.